These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia? Bèïque L; Por CP; Evans MF Can Fam Physician; 1998 Dec; 44():2659-62. PubMed ID: 9870119 [No Abstract] [Full Text] [Related]
6. The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation. Arikan G; Demir O; Yaman A; Bozkurt O; Saatci AO; Durak I; Esen A Ann Ophthalmol (Skokie); 2008; 40(1):19-21. PubMed ID: 18556976 [TBL] [Abstract][Full Text] [Related]
7. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Djavan B; Marberger M Eur Urol; 1999; 36(1):1-13. PubMed ID: 10364649 [TBL] [Abstract][Full Text] [Related]
8. Current role of alpha-blockers in the treatment of benign prostatic hyperplasia. Kaplan SA BJU Int; 2008 Nov; 102 Suppl 2():3-7. PubMed ID: 19032603 [No Abstract] [Full Text] [Related]
9. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study]. Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599 [No Abstract] [Full Text] [Related]
10. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia]. MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605 [No Abstract] [Full Text] [Related]
11. Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia. Mensink HJ Prog Clin Biol Res; 1994; 386():285-9. PubMed ID: 7528396 [No Abstract] [Full Text] [Related]
12. Medical therapy for benign prostatic hyperplasia: a review of the literature. Clifford GM; Farmer RD Eur Urol; 2000 Jul; 38(1):2-19. PubMed ID: 10859436 [TBL] [Abstract][Full Text] [Related]
13. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Lowe FC Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685 [TBL] [Abstract][Full Text] [Related]
14. Treatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers. Belayneh M; Korownyk C Can Fam Physician; 2016 Sep; 62(9):e523. PubMed ID: 27629686 [No Abstract] [Full Text] [Related]
15. [Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?]. Bar-Yosef Y; Mabjeesh NJ; Laufer M; Neulander EZ; Kaver I; Matzkin H Harefuah; 2008 Jun; 147(6):514-9, 574. PubMed ID: 18693628 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Pool JL; Kirby RS Int Urol Nephrol; 2001; 33(3):407-12. PubMed ID: 12230262 [TBL] [Abstract][Full Text] [Related]
18. Bunazosin. Andante, Detantol, E 1015, E 643, EA 0643. Drugs R D; 1999 Dec; 2(6):417-9. PubMed ID: 10763455 [No Abstract] [Full Text] [Related]
19. Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia. Kawabe K Br J Urol; 1995 Jul; 76 Suppl 1():63-7. PubMed ID: 7544217 [No Abstract] [Full Text] [Related]
20. Stroke associated with alpha blocker therapy for benign prostatic hypertrophy. Mansoor GA; Tendler BE J Natl Med Assoc; 2002 Jan; 94(1):1-4. PubMed ID: 11837346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]